摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

D-altro-Heptulose | 3019-74-7

中文名称
——
中文别名
——
英文名称
D-altro-Heptulose
英文别名
(3S,4R,5S,6R)-2,6-bis(hydroxymethyl)oxane-2,3,4,5-tetrol
D-altro-Heptulose化学式
CAS
3019-74-7
化学式
C7H14O7
mdl
——
分子量
210.18
InChiKey
HAIWUXASLYEWLM-QTSLKERKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    249 °C
  • 沸点:
    628.0±55.0 °C(Predicted)
  • 密度:
    1.645±0.06 g/cm3(Predicted)
  • 溶解度:
    Easily soluble (water), slightly soluble (ethanol)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.9
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    131
  • 氢给体数:
    6
  • 氢受体数:
    7

安全信息

  • 海关编码:
    2914400090

SDS

SDS:5517c1149c41abcf5035c62b3c892a03
查看

文献信息

  • Use of sedoheptulose as a nutritional supplement
    申请人:Medizinische Universität Wien
    公开号:EP2781218A1
    公开(公告)日:2014-09-24
    The invention discloses the use of sedoheptulose as a nutritional supplement.
    本发明公开了色甘酸作为营养补充剂的用途。
  • Use of sedoheptulose for prevention or treatment of inflammation
    申请人:Medizinische Universität Wien
    公开号:EP2781219A1
    公开(公告)日:2014-09-24
    The invention discloses sedoheptulose for use in the prevention or treatment of inflammation.
    本发明公开了用于预防或治疗炎症的色甘酸
  • PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL
    申请人:Inbiose N.V.
    公开号:EP3954769A1
    公开(公告)日:2022-02-16
    The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of fermentation of metabolically engineered cells. The present invention provides a method for the production of a mixture of at least two different oligosaccharides by a cell as well as the purification of at least one of said oligosaccharides from the cultivation. In addition, the present invention provides a method for the production of a mixture of at least two different oligosaccharides by a metabolically engineered cell as well as the purification of at least one of said oligosaccharides from the cultivation.
    本发明属于合成生物学和代谢工程技术领域。更具体地说,本发明属于代谢工程细胞发酵技术领域。本发明提供了一种细胞生产至少两种不同低聚糖混合物的方法,以及从培养物中纯化至少一种所述低聚糖的方法。此外,本发明还提供了一种通过代谢工程细胞生产至少两种不同低聚糖混合物以及从培养物中纯化至少一种所述低聚糖的方法。
  • PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL
    申请人:Inbiose N.V.
    公开号:EP3954778A1
    公开(公告)日:2022-02-16
    The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of fermentation of metabolically engineered cells. The present invention describes a metabolically engineered cell for production of a mixture of at least three different neutral non-fucosylated oligosaccharides. Furthermore, the present invention provides a method for the production of a mixture of at least three different neutral non-fucosylated oligosaccharides by a cell as well as the purification of at least one of said oligosaccharides from the cultivation.
    本发明属于合成生物学和代谢工程技术领域。更具体地说,本发明属于代谢工程细胞发酵技术领域。本发明描述了一种用于生产至少三种不同中性非岩藻糖基化低聚糖混合物的代谢工程细胞。此外,本发明还提供了一种细胞生产至少三种不同的中性非琥珀酰化低聚糖混合物的方法,以及从培养物中纯化至少一种所述低聚糖的方法。
  • USE OF SEDOHEPTULOSE AS A NUTRITIONAL SUPPLEMENT
    申请人:Medizinische Universität Wien
    公开号:EP2976088A1
    公开(公告)日:2016-01-27
查看更多